Chartwell Investment Partners, LLC Halozyme Therapeutics, Inc. Transaction History

Chartwell Investment Partners, LLC

  • $2.91 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Jul 25, 2023
SELL
$30.28 - $38.74 $303,678 - $388,523
-10,029 Reduced 42.36%
13,649 $492,000
Q1 2023

Apr 14, 2023
BUY
$32.86 - $55.7 $220,293 - $373,412
6,704 Added 39.5%
23,678 $905,000
Q4 2022

Feb 15, 2023
BUY
$40.06 - $59.44 $679,978 - $1.01 Million
16,974 New
16,974 $966,000

Others Institutions Holding HALO

# of Institutions
543
Shares Held
125M
Call Options Held
294K
Put Options Held
180K
View Full List

About HALOZYME THERAPEUTICS, INC.

HALO Quotes by TradingView
  • Ticker HALO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 139,288,992
  • Market Cap $6.62B
  • Description
  • Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...
More about HALO
Track This Portfolio

Track Chartwell Investment Partners, LLC Portfolio

Follow Chartwell Investment Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Chartwell Investment Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Chartwell Investment Partners, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email